Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Shukra Pharmaceuticals Ltd. lags significantly behind its peers in growth and profitability metrics, making it a high-risk investment. Meanwhile, companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. show strong performance in profitability and growth, indicating their market leadership and better investment potential.
Strong revenue and EPS growth (YoY: 8.42%, EPS: 45.55), high ROE (16.13%), indicating solid profitability.
High profitability with ROE of 21.76%, strong EPS growth (YoY: 16.54%, EPS: 68.07), and low valuation ratios.
Excellent valuation metrics (PE: 23.73, PEG: 0.35) combined with strong growth (YoY: 13.28%), making it a value pick.